Diabetes and high blood pressure shorten lifespan in Alzheimer's disease

NewsGuard 100/100 Score

People with Alzheimer's disease who also have diabetes or high blood pressure may die sooner than people without such disorders, according to a study published in the November 4, 2008, issue of Neurology, the medical journal of the American Academy of Neurology.

The study involved 323 people who had no memory problems when first tested but later developed dementia. Memory tests and physical exams were then given every 18 months.

The study found that after an Alzheimer's diagnosis was made, people with diabetes were twice as likely to die sooner than those without diabetes who had Alzheimer's disease. People with Alzheimer's disease who had high blood pressure were two-and-a-half times more like to die sooner than those with normal blood pressure.

"Studies show that the average lifespan of a person diagnosed with Alzheimer's can be anywhere from three to nine years. For that person and their caregiver, every minute counts. Here we have two controllable factors that may drastically affect how long that person can survive," said study author Yaakov Stern, PhD, professor at the Taub Institute for Research on Alzheimer's Disease and the Aging Brain and director of the Cognitive Neuroscience Division of Gertrude H. Sergievsky Center at Columbia University Medical Center in New York. Stern is also a member of the American Academy of Neurology.

The study also looked at how race could affect how long a person lives with Alzheimer's disease. It found Hispanic people lived for eight years after diagnosis, about four years longer than non-Hispanic white people did. African-Americans lived an average of five years, longer than non-Hispanic whites but not as long as Hispanic people. However, after adjusting for gender and other factors, the results were no longer significant.

"Though these findings were not significant, they are intriguing and warrant further research as to whether race affects survival time in people with Alzheimer's disease," said Stern.

Comments

The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News Medical.
Post a new comment
Post

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.

You might also like...
New insights to optimize telehealth for diabetes care